Systems of Governance in the Age of AI
Governance, at its core, is about how we relate to one another. It is not just about laws or procedures. It is about who is heard, how power moves, who decides what matters, and how decisions are made real through collective agreement. Governance lives not only in
Sean McArthur has joined the OG+S team as a law clerk. He brings a background in regulatory compliance, pharmaceutical operations, and surgical hospital administration—plus a flair for storytelling that somehow makes even clinical protocols read like character arcs. He’s proving to be that kind of person that has the kind of unshakeable curiosity that makes
On July 7, 2025, the European Commission presented its Roadmap Towards Nature Credits, setting the blueprint for biodiversity certification in the EU. The Communication was also accompanied by a Q&A and a call for feedback by 30 September 2025.
Nature Credits: Practical Uses Across Sectors
In short, nature credits will constitute quantifiable and fungible
When a federal agency reverses course, the Supreme Court has a test to determine whether that agency action is impermissibly “arbitrary and capricious.” FCC v. Fox Television Stations, Inc., 556 U.S. 502 (2009), set the current APA standard for review of federal agency flipflops. While no “heightened standard” exists under the APA for reversals of
The 34th session of the Codex Alimentarius Committee on General Principles (CCGP34) successfully addressed all topics on its agenda. CCGP34 endorsed several proposed key changes to the Procedural Manual of the Codex Alimentarius Commission relating to (a) the guidelines for Codex subsidiary bodies (Committees and Task Forces), (b) inconsistencies in language used in the main
In April, the Federal Circuit issued a significant patent law ruling involving artificial intelligence. In Recentive Analytics, Inc. v. Fox Corp, the Court addressed a core question facing many AI-driven businesses: When are solutions applying machine learning to real-world problems inventive and patentable? The Federal Circuit affirmed the trial court’s dismissal of the underlying
In an interesting and somewhat unexpected turnabout over the last six months, FDA has pivoted its focus from regulating industry’s use of artificial intelligence (“AI”) to how the agency itself utilizes AI. This internal shift marks a departure from FDA’s development of AI guidance over the last few years.
On the heels of the recent reintroduction of the PERA and PREVAIL Acts of 2025, a bipartisan group of lawmakers in Congress has introduced the Leadership in Critical and Emerging Technologies (“CET”) Act. The goal of the Leadership in CET Act is to “encourage innovation by, and the leadership of, the United States with
I’ve been thinking about a question raised by Dario Amodei, CEO of Anthropic, in his recent piece, “The Urgency of Interpretability.” He writes about the increasing power of artificial intelligence systems and our unsettling lack of insight into how they actually work. The models are getting stronger. Our ability to understand them is not.
This